Short-Term Mechanical Circulatory Support Before Heart Transplantation and Early Outcomes: Insights From the International Primary Graft Dysfunction Consortium
Journal of Cardiac Failure · 2026
DOI: 10.1016/j.cardfail.2026.06.022 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Cardiac Failure, 2026. Verfasst von Mercedes Rivas-Lasarte und 31 weiteren Autor:innen. Beteiligte Einrichtung: Cardiology Department, Puerta de Hierro University Hospital, Majadahonda, Madrid, Spain; Puerta de Hierro-Segovia de Arana Biomedical Research Instit…. Hauptthemen laut MEDLINE: Heart Transplantation, Primary Graft Dysfunction, Extracorporeal Membrane Oxygenation, Heart Failure. Die Arbeit nennt 25 Literaturangaben. Gefördert von: Spanish Society of Cardiology.
Abstract (Originalsprache)
BACKGROUND: Heart transplantation (HT) remains the gold-standard therapy for selected patients with advanced heart failure. Increasing recipient complexity and donor organ scarcity have led to the increased use of short-term mechanical circulatory support (ST-MCS) as a bridge to HT. The prognostic impact of ST-MCS on primary graft dysfunction (PGD) and other early outcomes remains limited. METHODS: We analyzed data from the Primary Graft Dysfunction Consortium, a retrospective registry including 3800 adult HTs at 14 centers in the United States, Canada, and Europe between 2010 and 2020. Primary outcomes were severe PGD (according to International Society for Heart and Lung Transplantation criteria) and 1-year mortality. Multivariable logistic regression and Cox models were used, with multiple imputation for missingness. RESULTS: Overall, 669 patients (17.6%) received pre-HT ST-MCS. Among them, 16.9% were supported with extracorporeal membrane oxygenation (ECMO), 60.4% with an intra-aortic balloon pump, 9.1% with a percutaneous left ventricular assist device, 9.1% with surgical ventricular assist devices, and 4.5% with other devices. ST-MCS use increased over time and varied by region, with the intra-aortic balloon pump predominating in the United States and ECMO more frequently used in Canada and Europe. Overall, ST-MCS was not associated with severe PGD after adjustment; however, ECMO was independently associated with greater PGD risk (adjusted odds ratio 3.28, 95% confidence interval 1.90-5.66). One-year mortality was 11.0% and did not differ significantly according to ST-MCS use after multivariable adjustment. CONCLUSIONS: In this large contemporary multinational cohort, pretransplant ST-MCS use has increased, with geographic heterogeneity observed. Although ECMO is associated with a greater risk of severe PGD, ST-MCS does not independently increase 1-year mortality after HT, supporting its use as a bridge in high-risk patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cardiology Department, Puerta de Hierro University Hospital, Majadahonda, Madrid, Spain; Puerta de Hierro-Segovia de Arana Biomedical Research Institute; CIBERCV. Electronic address: rivaslasarte@gmail.com.
- Cardiology Department, Vall d'Hebron University Hospital, Barcelona, Spain; CIBERCV; Ajmera Transplant Centre, University Health Network, Toronto, Ontario, Canada. Electronic address: eduard.rodenas@gmail.com.
- Ajmera Transplant Centre, University Health Network, Toronto, Ontario, Canada. Electronic address: yas.Moayedi@uhn.ca.
- Department of Medicine, University of Texas Southwestern Medical Center, Dallas, Texas. Electronic address: Lauren.Truby@utsouthwestern.edu.
- Ted Rogers Computational Program, University Health Network, Toronto, Ontario, Canada. Electronic address: Farid.Foroutan@uhn.ca.
- Department of Medicine, Stanford University, Stanford, California. Electronic address: ehenricksen@stanfordhealthcare.org.
Förderung
- Spanish Society of Cardiology
Zitieren
APA
Rivas-Lasarte, M., Rodenas-Alesina, E., Moayedi, Y., Truby, L. K., Foroutan, F., Henricksen, E., Signorile, M., Dhingra, N. K., Hastenteufel, L., Fan, C. S., Guzman-Bofarull, J., Farrero-Torres, M., Khush, K. K., Couto-Mallon, D., Moayedifar, R., Kim, G., Crespo-Leiro, M. G., Chih, S., Devore, A. D., …, & Hall, S. A. (2026). Short-Term Mechanical Circulatory Support Before Heart Transplantation and Early Outcomes: Insights From the International Primary Graft Dysfunction Consortium. Journal of Cardiac Failure. https://doi.org/10.1016/j.cardfail.2026.06.022
Vancouver
Rivas-Lasarte M, Rodenas-Alesina E, Moayedi Y, Truby LK, Foroutan F, Henricksen E, et al. Short-Term Mechanical Circulatory Support Before Heart Transplantation and Early Outcomes: Insights From the International Primary Graft Dysfunction Consortium. Journal of Cardiac Failure. 2026. doi:10.1016/j.cardfail.2026.06.022
BibTeX
@article{RivasLasarte2026,
author = {Rivas-Lasarte, Mercedes and Rodenas-Alesina, Eduard and Moayedi, Yasbanoo and Truby, Lauren K and Foroutan, Farid and Henricksen, Erik and Signorile, Marisa and Dhingra, Nitish K and Hastenteufel, Laura and Fan, Chun-Po S and Guzman-Bofarull, Joan and Farrero-Torres, Marta and Khush, Kiran K and Couto-Mallon, David and Moayedifar, Roxana and Kim, Gene and Crespo-Leiro, Maria Generosa and Chih, Sharon and Devore, Adam D and Takeda, Koji and Lerman, Joseph B and Sabatino, Mario and Potena, Luciano and Tremblay-Gravel, Maxime and Noly, Pierre-Emmanuel and Miller, Robert J H and Zuckermann, Andreas and Farr, Maryjane A and Ross, Heather J and Martin, Archer K and Segovia-Cubero, Javier and Hall, Shelley A},
title = {Short-Term Mechanical Circulatory Support Before Heart Transplantation and Early Outcomes: Insights From the International Primary Graft Dysfunction Consortium},
journal = {Journal of Cardiac Failure},
year = {2026},
doi = {10.1016/j.cardfail.2026.06.022}
}
EUVIMED